Related Experiment Video
Updated: Apr 21, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Overcoming Methicillin-Resistant Staphylococcus aureus Infections by Disrupting Membrane Integrity and Inducing DNA
Ting Xu1, Xiaoting Yan2, Ingting Wang2
1Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, Hunan Province, China.
Abstract:
The rise of multidrug-resistant bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA), poses a serious threat to human health, necessitating an urgent need to develop innovative antibacterials with multifunctions for this. Here, focusing on integrating multi-antimicrobial mechanisms with visual monitoring, we report a novel phenanthro[9,10-d]imidazole fluorogen 9b, outstanding for its antibacterial effects against S. aureus and various clinical MRSA isolates (minimum inhibitory concentration = 0.5 to 1 μg/ml) with rapid bactericidal activity, high membrane selectivity, and low susceptibility to drug resistance. Further investigation revealed its dual antimicrobial mechanisms of action by concurrently disrupting bacterial cell membranes and inducing bacterial DNA degradation to accelerate bacterial death. Ultraviolet-visible and fluorescence spectroscopy studies showed that the fluorescence intensity of 9b was dramatically enhanced when it interacted with S. aureus. Notably, in vivo studies demonstrated that 9b effectively treated both skin and thigh MRSA infections, showing a favorable safety profile and superior efficacy compared to the first-line antibiotic vancomycin. The "dual-mechanism" fluorescent phenanthro[9,10-d]imidazole fluorogen 9b holds promise as a candidate for developing innovative antibacterial agents that enable simultaneous real-time diagnosis and treatment.
Insights
A new fluorescent compound, 9b, shows potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). It works by dual mechanisms, disrupting bacterial membranes and DNA, offering a promising solution for MRSA infections.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Antimicrobial Research
Background:
- Multidrug-resistant bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA), represent a significant global health threat.
- There is an urgent need for novel antibacterial agents with enhanced efficacy and multiple mechanisms of action to combat resistance.
- Current treatments face challenges due to emerging resistance and limited therapeutic options.
Purpose of the Study:
- To develop and characterize a novel fluorescent phenanthro[9,10-d]imidazole derivative (9b) with dual antimicrobial functions.
- To investigate the antibacterial efficacy of compound 9b against Staphylococcus aureus and MRSA isolates.
- To explore the potential of 9b as a diagnostic and therapeutic agent for MRSA infections.
Main Methods:
- Synthesis and characterization of the phenanthro[9,10-d]imidazole fluorogen 9b.
- Determination of minimum inhibitory concentrations (MIC) against S. aureus and MRSA.
- Evaluation of bactericidal activity, membrane selectivity, and potential for drug resistance.
- Investigation of antimicrobial mechanisms using spectroscopic techniques (UV-Vis, fluorescence).
- In vivo efficacy studies in mouse models of MRSA skin and thigh infections.
Main Results:
- Compound 9b demonstrated potent antibacterial activity against S. aureus and MRSA isolates with MIC values of 0.5-1 μg/ml.
- 9b exhibited rapid bactericidal effects, high membrane selectivity, and low susceptibility to resistance development.
- Dual antimicrobial mechanisms were identified: disruption of bacterial cell membranes and induction of bacterial DNA degradation.
- Fluorescence intensity of 9b significantly increased upon interaction with S. aureus, enabling visual monitoring.
- In vivo studies showed 9b effectively treated MRSA infections with a favorable safety profile, outperforming vancomycin.
Conclusions:
- The novel fluorescent phenanthro[9,10-d]imidazole 9b possesses potent dual-action antibacterial properties against MRSA.
- Compound 9b offers a promising platform for developing innovative antibacterial agents with integrated diagnostic and therapeutic capabilities.
- Its unique mechanisms and visual monitoring potential make it a valuable candidate for combating challenging MRSA infections.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Inhibitors of Bacterial Protein Synthesis
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Inhibitors of Gram-positive Cell Wall Synthesis

